Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07300332

Exercise Training and Vitamin D Metabolism

The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D [25(OH)D] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.

Recruiting

Interested in participating?

Request Info

Key information

Age range

35 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Physical Education and Sport Science, University of Thessaly

Trikala, Karyes, 42100, Greece

Location status: Recruiting

Location contact

Athanasios Z Jamurtas, PhD

CONTACT

[email protected]

2431047054

Eytychia Giouvri, BSc

SUB_INVESTIGATOR

Ioannis G Fatouros, PhD

CONTACT

[email protected]

2431047047

About this study

Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI = 25-35 kg/m2
  • Absence of musculoskeletal injuries
  • Absence of chronic health-related complications
  • Non-smokers

Exclusion criteria

  • Consumption of Vitamin D supplements
  • Consumption of anti-inflammatory drugs, statins and/or steroids

Treatment and study plan

Exercise training

Other

Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period

Control

Other

Receive a balanced diet but abstain from any type of exercise training

Primary outcomes

  1. Change in 25-hydroxyvitamin D concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    25-OH-VD will be quantitatively determined in serum

  2. Change in plasma Vitamin D binding protein concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    Vitamin D binding protein concentration will be determined in plasma

  3. Change in calcium concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    Calcium concentration will be determined in serum

  4. Change in albumin concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    Albumin concentration will be determined in serum

  5. Change in aspartate aminotransferase (SGOT) concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    SGOT concentration will be determined in serum on a Clinical Chemistry analyzer

  6. Change in alanine aminotransferase (SGPT) concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    SGPT concentration will be determined in serum on a Clinical Chemistry analyzer

  7. Change in gamma-glutamyl transferase (γ-GT) concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer

Secondary outcomes

  1. Change in reduced glutathione concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    Reduced glutathione concentration will be determined in blood erythrocytes

  2. Change in oxidized glutathione concentration

    Time frame: At baseline, 6 weeks and 12 weeks

    Oxidized glutathione concentration will be determined in blood erythrocytes

  3. Change in dietary intake

    Time frame: At baseline, 6 weeks and 12 weeks

    Dietary intake habits will be assessed through dietary recalls

  4. Change in physical activity level

    Time frame: At baseline, 6 weeks and 12 weeks

    Physical activity will be assessed via accelerometry

  5. Change in body composition

    Time frame: At baseline, 6 weeks and 12 weeks

    Body composistion will be assessed via bioelectrical impedance analysis (BIA)

Study contacts

Contact information is provided by the study sponsor or research team.

Dimitrios Draganidis, PhD

CONTACT

[email protected]

+302431047078

Ioannis G Fatouros, PhD

CONTACT

[email protected]

2431047047

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Official study title

The Impact of Hybrid-type High-intensity Interval Training on Vitamin D Metabolism in Adults With Overweight/Obesity

Acronym: Hybri-D

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 23, 2025
Registry last updated
May 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.